Search results
-
Scientific Publication
Nanomilling from Screening to Scale-up
Altasciences determines the suitability of nano milling for a client’s highly active compound with very poor aqueous solubility and less than desirable bioavailability.
-
Scientific Publication
Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.
-
Blog
Disrupting the CRO Model: Altasciences Participates in Documentary Series for 2024 Global Health Summit
Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.
-
Blog
Genetic therapies – part 2 of a 2-part series
In our February 3rd blog, we discussed the difference between genetics and genomics. Today, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.
-
Blog
Exploring the Advantages of Canada for Early-Phase Clinical Trials
Explore Canada `s advantages for early-phase clinical trials: streamlined regulatory pathways, diverse participant pool, and cost-effectiveness.